[/fusion_text]
ControlRad Select imaging system gains FDA market clearance
ControlRad has announced US Food and Drug Administration (FDA) 510(k) clearance to market Contro...
Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial
Favourable rates of ischaemic outcomes were observed among selected high bleeding risk patients ...
Societies collaborate to develop universal heart failure definition
A global collaboration between international heart failure bodies seeks to standardise the language ...
MedAlliance gains FDA breakthrough designation for sirolimus DEB treatment of de novo coronary lesions
MedAlliance has been awarded breakthrough status for Selution SLR, its sustained limus release drug-...
